{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:08:36Z","timestamp":1794586116958,"version":"4.9.1"},"reference-count":36,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Research Foundation - Flanders","doi-asserted-by":"publisher","award":["1506114N"],"award-info":[{"award-number":["1506114N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation - Flanders","doi-asserted-by":"publisher","award":["G053121N"],"award-info":[{"award-number":["G053121N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation - Flanders","doi-asserted-by":"publisher","award":["G057721N"],"award-info":[{"award-number":["G057721N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation - Flanders","doi-asserted-by":"publisher","award":["1186121N"],"award-info":[{"award-number":["1186121N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["C24\/17\/061"],"award-info":[{"award-number":["C24\/17\/061"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Influenza-associated pulmonary aspergillosis (IAPA) is a global recognized superinfection in critically ill influenza patients. Baloxavir marboxil, a cap-dependent endonuclease inhibitor, is a newly approved anti-influenza therapeutic. Although the benefits as a treatment for influenza are clear, its efficacy against an influenza-A. fumigatus co-infection has yet to be determined. We investigated the therapeutic effect of baloxavir marboxil in a murine model for IAPA. Immunocompetent mice received intranasal instillation of influenza A followed by orotracheal inoculation with Aspergillus fumigatus 4 days later. Administration of baloxavir marboxil or sham was started at day 0, day 2 or day 4. Mice were monitored daily for overall health status, lung pathology with micro-computed tomography (\u00b5CT) and fungal burden with bioluminescence imaging (BLI). In vivo imaging was supplemented with virological, mycological and biochemical endpoint investigations. We observed an improved body weight, survival and viral clearance in baloxavir marboxil treated mice. \u00b5CT showed less pulmonary lesions and bronchial dilation after influenza and after Aspergillus co-infection in a treatment-dependent pattern. Furthermore, baloxavir marboxil was associated with effective inhibition of fungal invasion. Hence, our results provide evidence that baloxavir marboxil mitigates severe influenza thereby decreasing the susceptibility to a lethal invasive Aspergillus superinfection.<\/jats:p>","DOI":"10.3390\/jof8010001","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T04:35:57Z","timestamp":1640061357000},"page":"1","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Overcome Double Trouble: Baloxavir Marboxil Suppresses Influenza Thereby Mitigating Secondary Invasive Pulmonary Aspergillosis"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9562-2923","authenticated-orcid":false,"given":"Laura","family":"Seldeslachts","sequence":"first","affiliation":[{"name":"Biomedical MRI Unit\/MoSAIC, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cato","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1775-1797","authenticated-orcid":false,"given":"Birger","family":"Tielemans","sequence":"additional","affiliation":[{"name":"Biomedical MRI Unit\/MoSAIC, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Vanhoffelen","sequence":"additional","affiliation":[{"name":"Biomedical MRI Unit\/MoSAIC, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Van der Sloten","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Humblet-Baron","sequence":"additional","affiliation":[{"name":"Laboratory of Adaptive Immunity, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9742-9302","authenticated-orcid":false,"given":"Lieve","family":"Naesens","sequence":"additional","affiliation":[{"name":"Laboratory of Virology and Chemotherapy, Rega Institute, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-1350","authenticated-orcid":false,"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Bacteriology and Mycology, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Verbeken","sequence":"additional","affiliation":[{"name":"Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Wauters","sequence":"additional","affiliation":[{"name":"Laboratory for Clinical Infectious and Inflammatory Disorders, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5633-3993","authenticated-orcid":false,"given":"Greetje","family":"Vande Velde","sequence":"additional","affiliation":[{"name":"Biomedical MRI Unit\/MoSAIC, Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jama.1979.03290400053024","article-title":"Invasive Pulmonary Aspergillosis Associated with Influenza","volume":"241","author":"Fischer","year":"1979","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QCO.0000000000000504","article-title":"Invasive pulmonary aspergillosis complicating severe influenza: Epidemiology, diagnosis and treatment","volume":"31","author":"Vanderbeke","year":"2018","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: An expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: A retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1164\/rccm.201612-2540LE","article-title":"Influenza-associated aspergillosis in critically ill patients","volume":"196","author":"Kolwijck","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: A retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/crj.13036","article-title":"Aspergillosis related to severe influenza: A worldwide phenomenon?","volume":"13","author":"Liu","year":"2019","journal-title":"Clin. Respir. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Feys, S., Almyroudi, M.P., Braspenning, R., Lagrou, K., Spriet, I., Dimopoulos, G., and Wauters, J. (2021). A Visual and Comprehensive Review on COVID-19-Associated. J. Fungi, 7.","DOI":"10.3390\/jof7121067"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Segala, F.V., Bavaro, D.F., Di Gennaro, F., Salvati, F., Marrota, C., Saracino, A., Murri, R., and Fantoni, M. (2021). Impact of SARS-CoV-2 epidemic on antimicrobial resistance: A literature review. Viruses, 13.","DOI":"10.3390\/v13112110"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Chen, L., Han, X., Li, Y., Zhang, C., and Xing, X. (2020). Invasive pulmonary aspergillosis in immunocompetent patients hospitalised with influenza A-related pneumonia: A multicenter retrospective study. BMC Pulm. Med., 20.","DOI":"10.1186\/s12890-020-01257-w"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1080\/21505594.2021.1974327","article-title":"Early oseltamivir reduces risk for influenza-associated aspergillosis in a double-hit murine model","volume":"12","author":"Seldeslachts","year":"2021","journal-title":"Virulence"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4049\/jimmunol.2000067","article-title":"Influenza Suppresses Neutrophil Recruitment to the Lung and Exacerbates Secondary Invasive Pulmonary Aspergillosis","volume":"205","author":"Tobin","year":"2020","journal-title":"J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.13309","article-title":"Prophylactic oseltamivir during major seasonal influenza H1N1 outbreak might reduce both H1N1 and associated pulmonary aspergillosis in children undergoing haploidentical transplantation","volume":"22","author":"Jaiswal","year":"2020","journal-title":"Transpl. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/AAC.00344-08","article-title":"Limited inhibitory effects of oseltamivir and zanamivir on human sialidases","volume":"52","author":"Hata","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"100289","DOI":"10.1016\/j.xcrm.2021.100289","article-title":"Neuraminidase and SIGLEC15 modulate the host defense against pulmonary aspergillosis","volume":"2","author":"Dewi","year":"2021","journal-title":"Cell Rep. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"105158","DOI":"10.1016\/j.antiviral.2021.105158","article-title":"Influenza polymerase inhibitor resistance: Assessment of the current state of the art\u2014A report of the isirv Antiviral group","volume":"194","author":"Ison","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_18","unstructured":"(2021, August 21). Antiviral Drug Resistance among Influenza Viruses, Available online: https:\/\/www.cdc.gov\/flu\/professionals\/antivirals\/antiviral-drug-resistance.htm."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/cid\/ciz904","article-title":"Oseltamivir resistance in severe influenza a (H1N1)pdm09 pneumonia and acute respiratory distress syndrome: A french multicenter observational cohort study","volume":"71","author":"Behillil","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/infdis\/jis337","article-title":"Characteristics of a widespread community cluster of H275Y oseltamivir-resistant a(H1N1)pdm09 influenza in Australia","volume":"206","author":"Hurt","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/tid.13542","article-title":"Baloxavir treatment of oseltamivir-resistant influenza A\/H1pdm09 in two immunocompromised patients","volume":"23","author":"Macesic","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"ref_22","unstructured":"(2021, August 21). FDA Approves New Drug to Treat Influenza, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-drug-treat-influenza."},{"key":"ref_23","unstructured":"(2021, August 11). Xofluza (Baloxavir Marboxil). Available online: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/xofluza."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jmii.2021.04.002","article-title":"Clinical efficacy and safety of baloxavir marboxil in the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials","volume":"54","author":"Kuo","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Fukao, K., Ando, Y., Noshi, T., Kitano, M., Noda, T., Kawai, M., Yoshida, R., Sato, A., Shishido, T., and Naito, A. (2019). Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0217307"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/jac\/dky462","article-title":"Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection","volume":"74","author":"Fukao","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_28","unstructured":"Resendiz-Sharpe, A., Peres Da Silva, R., and Geib, E. Longitudinal multimodal imaging-compatible mouse model of triazole sensitive and resistant invasive pulmonary aspergillosis, Under Consideration."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.micinf.2007.11.001","article-title":"Characterisation of the phagocytic uptake of Aspergillus fumigatus conidia by macrophages","volume":"10","author":"Luther","year":"2008","journal-title":"Microbes Infect."},{"key":"ref_30","first-page":"1","article-title":"Aspergillus fumigatus and Aspergillosis in 2019","volume":"33","author":"Chamilos","year":"2020","journal-title":"Am. Soc. Microbiol. Clin. Microbiol. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1172\/JCI57762","article-title":"Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice","volume":"121","author":"Nakamura","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Salazar, F., Bignell, E., Brown, G.D., Cook, P.C., and Warris, A. (2021). Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin. Microbiol. Rev.","DOI":"10.1128\/CMR.00094-21"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nm1765","article-title":"Inhibition of pulmonary antibacterial defense by interferon-\u03b3 during recovery from influenza infection","volume":"14","author":"Sun","year":"2008","journal-title":"Nat. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/fcp.12213","article-title":"Unexpected platelets elevation in a patient with idiopathic thrombocytopenia treated with oseltamivir for influenza infection","volume":"30","author":"Bigot","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"106155","DOI":"10.1016\/j.ijantimicag.2020.106155","article-title":"Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection","volume":"56","author":"Groeneveld","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S2213-2600(14)70041-4","article-title":"Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: A meta-analysis of individual participant data","volume":"2","author":"Muthuri","year":"2014","journal-title":"Lancet Respir. Med."}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/1\/1\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:50:13Z","timestamp":1760169013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/1\/1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["jof8010001"],"URL":"https:\/\/doi.org\/10.3390\/jof8010001","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,21]]}}}